PL2851073T3 - Środek profilaktyczny i/lub środek terapeutyczny do leczenia wysiłkowego nietrzymania moczu - Google Patents
Środek profilaktyczny i/lub środek terapeutyczny do leczenia wysiłkowego nietrzymania moczuInfo
- Publication number
- PL2851073T3 PL2851073T3 PL13790782T PL13790782T PL2851073T3 PL 2851073 T3 PL2851073 T3 PL 2851073T3 PL 13790782 T PL13790782 T PL 13790782T PL 13790782 T PL13790782 T PL 13790782T PL 2851073 T3 PL2851073 T3 PL 2851073T3
- Authority
- PL
- Poland
- Prior art keywords
- agent
- urinary incontinence
- stress urinary
- therapeutic agent
- prophylactic
- Prior art date
Links
- 206010066218 Stress Urinary Incontinence Diseases 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
- C07D211/50—Aroyl radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012111843 | 2012-05-15 | ||
| EP13790782.0A EP2851073B1 (en) | 2012-05-15 | 2013-05-14 | Prophylactic agent and/or therapeutic agent for stress urinary incontinence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2851073T3 true PL2851073T3 (pl) | 2017-06-30 |
Family
ID=49583744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13790782T PL2851073T3 (pl) | 2012-05-15 | 2013-05-14 | Środek profilaktyczny i/lub środek terapeutyczny do leczenia wysiłkowego nietrzymania moczu |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9603845B2 (pl) |
| EP (1) | EP2851073B1 (pl) |
| JP (1) | JP5908072B2 (pl) |
| CN (1) | CN104302293B (pl) |
| ES (1) | ES2612827T3 (pl) |
| PL (1) | PL2851073T3 (pl) |
| TW (1) | TWI544925B (pl) |
| WO (1) | WO2013172339A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE496134T1 (de) | 2002-03-29 | 2011-02-15 | Xoma Technology Ltd | Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden |
| WO2020101586A1 (en) | 2018-11-16 | 2020-05-22 | Santa Farma İlaç Sanayi̇ A.Ş. | Controlled release propiverine formulations |
| EP4251154A4 (en) | 2020-11-27 | 2024-07-31 | Santa Farma Ilac Sanayii A.S. | SUSTAINED-RELEASE FORMULATION COMPOSITIONS COMPRISING PROPIVERINE |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD139212A1 (de) | 1978-10-09 | 1979-12-19 | Christian Starke | Verfahren zur herstellung eines neuen arzneimittels aus alpha,alpha-diphenyl-alpha-alkoxyessigsaeure-1-methylpiperidyl-4-ester-derivaten |
| JPH0611758B2 (ja) | 1985-08-14 | 1994-02-16 | 大鵬薬品工業株式会社 | ベンジル酸−４−ピペリジルエステル誘導体 |
-
2013
- 2013-05-14 TW TW102117019A patent/TWI544925B/zh active
- 2013-05-14 US US14/388,289 patent/US9603845B2/en active Active
- 2013-05-14 JP JP2014515634A patent/JP5908072B2/ja active Active
- 2013-05-14 WO PCT/JP2013/063409 patent/WO2013172339A1/ja not_active Ceased
- 2013-05-14 EP EP13790782.0A patent/EP2851073B1/en active Active
- 2013-05-14 CN CN201380023152.7A patent/CN104302293B/zh active Active
- 2013-05-14 PL PL13790782T patent/PL2851073T3/pl unknown
- 2013-05-14 ES ES13790782.0T patent/ES2612827T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2851073A4 (en) | 2015-10-28 |
| WO2013172339A1 (ja) | 2013-11-21 |
| EP2851073B1 (en) | 2016-11-09 |
| JP5908072B2 (ja) | 2016-04-26 |
| US9603845B2 (en) | 2017-03-28 |
| HK1203159A1 (en) | 2015-10-23 |
| CN104302293A (zh) | 2015-01-21 |
| ES2612827T3 (es) | 2017-05-18 |
| EP2851073A1 (en) | 2015-03-25 |
| US20150051250A1 (en) | 2015-02-19 |
| CN104302293B (zh) | 2017-03-15 |
| JPWO2013172339A1 (ja) | 2016-01-12 |
| TW201350118A (zh) | 2013-12-16 |
| TWI544925B (zh) | 2016-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL222702A0 (en) | Incontinence treatment | |
| EP2709562A4 (en) | FABRIC BACKUP DEVICES AND USE METHOD THEREFOR | |
| EP2785275A4 (en) | TREATMENT OF HARNINE CONTINENCE | |
| RS67768B1 (sr) | Terapijski agens koji indukuje citotoksičnost | |
| PL2802300T3 (pl) | Chirurgiczny zestaw i urządzenie do leczenia jaskry | |
| GB201012175D0 (en) | Procedure and mechanisms | |
| EP2655334A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES | |
| EP2437743A4 (en) | OPHTHALMIC FORMULATIONS OF FLUTICASONE AND METHODS OF USE | |
| EP2627331A4 (en) | METHODS OF TREATING HYPERURICEMIA AND RELATED DISEASES | |
| GB2498150B (en) | Orthotic device and method | |
| DK3292875T3 (en) | Compositions and methods for treating diseases | |
| SG11201500407XA (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
| ZA201406146B (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
| EP2931140A4 (en) | Tissue repair equipment and methods | |
| PL2529739T3 (pl) | Środek terapeutyczny lub profilaktyczny na choroby dróg żółciowych | |
| IL222479A0 (en) | Devices and methods for tissue engineering | |
| IL236226A0 (en) | Medicinal or prophylactic agent for mild cognitive impairment | |
| PL2554541T3 (pl) | Środek terapeutyczny lub środek profilaktyczny na fibromialgię | |
| EP2663343A4 (en) | DEVICES AND METHODS FOR TISSUE ENGINEERING | |
| EP2534533A4 (en) | METHODS AND DEVICES FOR HALO-OUT AXIS REDUCTION | |
| IL224632A (en) | Fentanyl docushexanavate and its use in the treatment and prevention of cardiovascular disease | |
| ZA201406668B (en) | Pharmaceutical composition for treating urinary incontinence and enuresis | |
| GB201011456D0 (en) | Compositions and methods for embolization therapy | |
| GB201003727D0 (en) | Therapeutic agent | |
| AU2012903508A0 (en) | Breast-protective orthosis and use thereof |